Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D01555 (
Ioversol
)
59
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mechanisms of contrast medium (CM)-induced renal impairment at cellular level are not fully understood. The purpose of this study was to investigate the toxic effects of non-ionic low osmolar contrast medium (LOCM) on glomerular endothelial cells (GECs).
Ioversol
, the most representative LOCM used in clinic, was chosen to act on primary cultured rat GECs. When rat GECs were treated with various amount of ioversol, a dose-dependent reduction in cell viability was observed by tetrazolium dye (
MTT
) assay. After exposure to ioversol at dose of 100 microl/ml for 24h, nuclear condensation, nuclear fragmentation, cell apoptosis and necrosis were found in GECs. The intracellular free Ca(2+) concentrations ([Ca(2+)]i) detected by confocal laser scanning were markedly elevated in GECs treated with ioversol. The [Ca(2+)]i increase, LDH release and expression changes of apoptotic associated proteins in GECs induced by ioversol could be reversed by pretreatment with intracellular Ca(2+) chelator, 1,2-bis (o-aminophenoxy) ethane-N,N,N',N'-tetra-acetic acid (BAPTA/AM). These results suggest that LOCM can decrease cell viability and cause cell injury of GECs. The elevation of [Ca(2+)]i released from intracellular calcium stores likely contribute to the LOCM-induced cell injury of GECs.
...
PMID:Low osmolar contrast medium induces cellular injury and disruption of calcium homeostasis in rat glomerular endothelial cells in vitro. 1913 47